Mesoporous silica nanoparticles conjugated with CD11b antibody (MSN-NGR1-CD11b) enhance cardiac repair by suppressing reactive oxygen species (ROS) accumulation through activation of AKT/MAPK signaling pathways in myocardial infarction (Li H. et al., 2022). This evidence concerns the gene RTN4R and myocardial infarction.